Board Approves Syndicated Credit Facility Application for Subsidiary Chainwin Biotech and Agrotech
Original: 本公司代重要子公司Chainwin Biotech and Agrotech (Cayman Islands) Co., Ltd.公告董事會通過向銀行申請聯合 授信案
Summary
WIN Semiconductors, acting on behalf of its material subsidiary Chainwin Biotech and Agrotech (Cayman Islands) Co., Ltd., announces that the subsidiary's board of directors has resolved to apply to a banking consortium for a syndicated credit facility. A syndicated credit arrangement pools committed credit lines from multiple banks, typically serving working-capital, capex, or refinancing purposes for the borrowing entity. Full body available on MOPS.
Full Translation
WIN Semiconductors (3105) hereby announces, on behalf of its important subsidiary Chainwin Biotech and Agrotech (Cayman Islands) Co., Ltd., that the subsidiary's board of directors has passed a resolution approving an application to banks for a syndicated credit facility (聯合授信案). In Taiwan capital-market practice, a '聯合授信案' denotes a consortium lending arrangement in which two or more financial institutions jointly extend credit to a single borrower under a unified credit agreement; board approval of the application is a regulatory disclosure trigger under TWSE material-information rules. The filing company (WIN Semiconductors, 穩懋) is acting as the disclosing parent on behalf of the Cayman-incorporated subsidiary. [Body not available — subject line only. See MOPS for full announcement.]